{"product_id":"timolol-0-25-ophthalmic-solution-10ml","title":"Timolol 0.25% Ophthalmic Solution 10mL","description":"\u003cp\u003e\u003cstrong\u003eNDC:\u003c\/strong\u003e 70756-655-30\u003c\/p\u003e\n\u003ch3\u003eTimolol Maleate Ophthalmic Solution 0.25%, 10 mL — Lifestar Pharma\u003c\/h3\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eActive ingredient\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTimolol maleate 3.4 mg\/mL (equivalent to timolol 2.5 mg\/mL, 0.25%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDosage form\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eOphthalmic solution, sterile, isotonic, buffered (preserved with benzalkonium chloride 0.01%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRoute\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eOphthalmic (topical)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSize\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e10 mL dropper bottle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eManufacturer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eManufactured for Lifestar Pharma LLC; product of Germany\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eNDC\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e70756-655-30\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch4\u003eIndications and Usage\u003c\/h4\u003e\n\u003cp\u003eIndicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.\u003c\/p\u003e\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eUsual starting dose is one drop in the affected eye(s) twice daily. If clinical response is inadequate, dosage may be changed to the 0.5% solution twice daily. If intraocular pressure is well controlled, dosage may be reduced to once daily. Doses above one drop of 0.5% twice daily generally produce no further IOP reduction. Concomitant use of two topical beta-blockers is not recommended.\u003c\/p\u003e\n\u003ch4\u003eWarnings and Precautions\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eSystemically absorbed; may cause the same cardiac and respiratory reactions as systemic beta-blockers, including death from bronchospasm in asthmatic patients and rarely death associated with cardiac failure\u003c\/li\u003e\n\u003cli\u003eMay precipitate cardiac failure in patients with diminished myocardial reserve; discontinue at first sign of cardiac failure\u003c\/li\u003e\n\u003cli\u003eShould generally not be used in patients with chronic obstructive pulmonary disease or bronchospastic disease\u003c\/li\u003e\n\u003cli\u003eMay mask signs of hypoglycemia in diabetic patients or signs of hyperthyroidism (e.g., tachycardia); avoid abrupt withdrawal in suspected thyrotoxicosis\u003c\/li\u003e\n\u003cli\u003eUse with caution in patients with cerebrovascular insufficiency\u003c\/li\u003e\n\u003cli\u003eBacterial keratitis has been reported with contaminated multi-dose ophthalmic containers; avoid touching the dropper tip to the eye or surrounding structures\u003c\/li\u003e\n\u003cli\u003eShould not be used alone in angle-closure glaucoma, as it has little to no effect on the pupil\u003c\/li\u003e\n\u003cli\u003ePatients with a history of atopy or severe anaphylactic reactions may be unresponsive to usual epinephrine doses used to treat anaphylaxis while on beta-blocker therapy\u003c\/li\u003e\n\u003cli\u003eMay potentiate muscle weakness in patients with myasthenia gravis or myasthenic symptoms\u003c\/li\u003e\n\u003cli\u003eContains benzalkonium chloride, which may be absorbed by soft contact lenses; remove lenses before use and wait at least 15 minutes before reinsertion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eContraindications\u003c\/h4\u003e\n\u003cp\u003eContraindicated in patients with bronchial asthma or history of bronchial asthma, severe chronic obstructive pulmonary disease, sinus bradycardia, second- or third-degree atrioventricular block, overt cardiac failure, cardiogenic shock, or hypersensitivity to any component of this product.\u003c\/p\u003e\n\u003ch4\u003eAdverse Reactions\u003c\/h4\u003e\n\u003cp\u003eMost frequently reported reaction is burning and stinging upon instillation (approximately 1 in 8 patients). Other reported reactions include headache, bradycardia, hypotension, dizziness, ocular irritation, conjunctivitis, keratitis, dry eyes, and, rarely, systemic allergic reactions including anaphylaxis.\u003c\/p\u003e\n\u003ch4\u003eStorage and Handling\u003c\/h4\u003e\n\u003cp\u003eStore at 20°C to 25°C (68°F to 77°F). Protect from freezing and light. After opening, may be used until the expiration date on the bottle.\u003c\/p\u003e\n\u003ch4\u003eHow Supplied\u003c\/h4\u003e\n\u003cp\u003eSupplied as a clear, colorless solution in a 10 mL natural LDPE bottle with a controlled drop tip and yellow HDPE cap.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eProfessional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.\u003c\/em\u003e\u003c\/p\u003e","brand":"Lifestar Pharmaceuticals","offers":[{"title":"Default Title","offer_id":53655419191661,"sku":"RX-1064","price":11.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/wholesale.dryeyerescue.com\/products\/timolol-0-25-ophthalmic-solution-10ml","provider":"Dryeye Rescue Pro","version":"1.0","type":"link"}